Piperacillin/tazobactam in the treatment of hospitalized patients with urinary tract infections: an open non-comparative and multicentered trial.

about

Complicated urinary tract infection in adults.

P2860

Q36170941-B654C9D3-26E8-404E-9434-A9BEB4E8B691

P2860

Piperacillin/tazobactam in the treatment of hospitalized patients with urinary tract infections: an open non-comparative and multicentered trial.

Item

http://www.wikidata.org/entity/Q40670277

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Piperacillin/tazobactam in the ...... ative and multicentered trial.

@en

type

Item

label

Piperacillin/tazobactam in the ...... ative and multicentered trial.

@en

prefLabel

Piperacillin/tazobactam in the ...... ative and multicentered trial.

@en

P1476

Piperacillin/tazobactam in the ...... ative and multicentered trial.

@en

P2093

A Dain

http://www.w3.org/2001/XMLSchema#string

A Jáuregui

http://www.w3.org/2001/XMLSchema#string

A Rodríguez-Toledo

http://www.w3.org/2001/XMLSchema#string

C Froiler

http://www.w3.org/2001/XMLSchema#string

C Sáenz-Aguirre

http://www.w3.org/2001/XMLSchema#string

E Jakob

http://www.w3.org/2001/XMLSchema#string

F J de la Cabada

http://www.w3.org/2001/XMLSchema#string

F Maglio

http://www.w3.org/2001/XMLSchema#string

G M Ruìz-Palacios

http://www.w3.org/2001/XMLSchema#string

I Conde-Carmona

http://www.w3.org/2001/XMLSchema#string

P2860

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Tre

Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.

Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.

Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.

Piperacillin/tazobactam in the treatment of lower respiratory tract infections: an open non-comparative and multicentered trial. Latin American Clinical Research Group.

The activity of piperacillin/tazobactam against clinical isolates collected in 20 UK centres and the design of a disc test for susceptibility testing.

Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactam.

Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases.

P304

122-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1179/JOC.1996.8.2.122

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1996-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8708743

http://www.w3.org/2001/XMLSchema#string

Piperacillin/tazobactam in the treatment of hospitalized patients with urinary tract infections: an open non-comparative and multicentered trial.

about

P2860

P2860

Piperacillin/tazobactam in the treatment of hospitalized patients with urinary tract infections: an open non-comparative and multicentered trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698